Oncology Research and Treatment

Abbr. ONCOL RES TREAT ·GERMANY ·Avg. articles/yr 85 articles

1.6

Latest IF

2.60%

Self-citation

Submission difficulty

About Journal

Oncology Research and Treatment是一本专注于肿瘤学领域的国际期刊，ISSN号为2296-5270，由瑞士的Karger出版社出版，出版地为瑞士巴塞尔，出版周期为月刊。该期刊的影响因子根据最新数据有所不同，具体需参考JCR报告，目前为非开放获取（非OA）期刊，被SCI收录，中科院分区情况需查阅最新分区表以确认。该杂志的发文特点涵盖肿瘤学的基础研究、临床实践、治疗进展及转化医学，重点关注多学科交叉研究，包括肿瘤生物学、免疫治疗、靶向治疗和个性化医疗等。其研究领域涉及各类恶性肿瘤的预防、诊断、治疗及预后评估。杂志的质量较高，审稿流程严格，但因肿瘤学领域竞争激烈，投稿难度较大，需注意研究创新性和临床价值。潜在风险包括拒稿率较高以及发表周期可能较长。总体而言，该期刊是肿瘤学领域具有一定影响力的学术平台。

IF Trend

Recent Articles

Efficacy and Safety of Prophylactic Tocilizumab in Patients with Multiple Myeloma Receiving Bispecific Antibodies: A Systematic Review and Meta-Analysis 2026-07-22

Precision Oncology in Northern Germany: Integrating Multi-Omics and Artificial Intelligence to Support Evidence-Based Molecular Tumor Boards 2026-07-16

Establishing a Multimodal Model for Predicting Lymphovascular Invasion in Breast Cancer Using Deep Transfer Learning Based on Ultrasound and Dynamic Contrast-Enhanced Magnetic Resonance Imaging 2026-07-10

Efficacy of Honey Combined with Cryotherapy in the Prevention and Management of Radiation-Induced Oral Mucositis in Patients Undergoing Concurrent Chemoradiotherapy for Head and Neck Cancer 2026-06-22

Three Therapeutic Modalities for Advanced Ovarian Cancer: Real-World Data from a Certified Oncological Center 2026-06-19

Real-World Experiences in the Treatment of Immune Thrombocytopenia over a 2-Year Period 2026-06-18

Safety and Preliminary Activity of Neoadjuvant Trastuzumab Deruxtecan plus 5-Fluorouracil and Folinic Acid for HER2-Positive, Resectable Esophagogastric Adenocarcinoma: Results from the Safety Run-In Cohort of the Phase Ib/II UCCL-AIO-STO0124-IKF072 NeoART Trial 2026-05-29

Genitourinary Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2025: Advances in Renal Cell Carcinoma and Muscle-Invasive Bladder Cancer 2026-05-29

In Memoriam: Prof. Dr. med. Wolfgang Queisser 2026-05-14

The Role of Regulatory Policies in Shaping Outpatient Cancer Treatment in Germany: A Comparative Perspective 2026-05-05